Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER METABOLISM

Upcycling the TCA cycle—rewiring tumour-associated fibroblasts

Alterations to the extracellular matrix have long been associated with cancer progression and therapeutic resistance. Schwörer et al. describe a mechanism whereby fibroblasts reroute metabolites to fuel the demands of collagen synthesis, leading to cancer progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Fibroblasts upregulate pyruvate carboxylase to obtain metabolic flexibility and sustain collagen production in a nutrient-poor tumour microenvironment.

References

  1. Rozario, T. & DeSimone, D. W. Dev. Biol. 341, 126–140 (2010).

    Article  CAS  Google Scholar 

  2. Zhang, R. et al. BMC Cancer 18, 901 (2018).

    Article  CAS  Google Scholar 

  3. Ignotz, R. A. & Massague, J. J. Biol. Chem. 261, 4337–4345 (1986).

    Article  CAS  Google Scholar 

  4. Bernard, K. et al. J. Biol. Chem. 293, 1218–1228 (2018).

    Article  CAS  Google Scholar 

  5. Hamanaka, R. B. et al. Am. J. Resp. Cell Mol. Biol. 61, 597–606 (2019).

    Article  CAS  Google Scholar 

  6. Schwörer, S. et al. EMBO J. 39, e103334 (2020).

    Article  Google Scholar 

  7. Voorde, J. V. et al. Sci. Adv. 5, eaau7314 (2019).

    Article  Google Scholar 

  8. Schwörer, S. et al. Nat. Metab. https://doi.org/10.1038/s42255-021-00480-x (2021).

    Article  PubMed  Google Scholar 

  9. Kalluri, R. Nat. Rev. Cancer 16, 582–598 (2016).

    Article  CAS  Google Scholar 

  10. Durning, P. & Schor, S. L. Lancet 324, 890–892 (1984).

    Article  Google Scholar 

  11. Schor, S. L. et al. J. Cell Sci. 90, 391–399 (1988).

    Article  CAS  Google Scholar 

  12. Zhu, J. et al. Science 372, 968–972 (2021).

    Article  CAS  Google Scholar 

  13. Pavlova, N. N. et al. eLife 9, e62307 (2020).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Fig. 1 was generated using BioRender and adapted from “PDAC Histology”, by BioRender.com (2021). Retrieved from https://app.biorender.com/biorender-templates.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Kimryn Rathmell.

Ethics declarations

Competing interests

W.K.R. declares research support from Incyte and support to an immediate family member as a founder, scientific advisory board member and stockholder of Sitryx Therapeutics; is a scientific advisory board member and stockholder of Caribou Biosciences; is a member of the scientific advisory board of Nirogy Therapeutics; and is a consultant for Merck, Pfizer, Mitobridge, Calithera Biosciences and Tempest Therapeutics. Z.A.B. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bacigalupa, Z.A., Rathmell, W.K. Upcycling the TCA cycle—rewiring tumour-associated fibroblasts. Nat Metab 3, 1439–1440 (2021). https://doi.org/10.1038/s42255-021-00473-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-021-00473-w

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer